X4 Pharmaceuticals Quote - XFOR

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.5497

Bid

0.5468

Ask

0.5497

Volume

10,604,576

0.5002 Day's Range 0.5999

0.2612 52 Week Range 1.60

Market Cap

93.749M

Previous Close

0.5701

Open

0.5994

Last Trade

0.547671

Last Trade Time

14:26:23

Financial Volume

US$ 5,691,018

VWAP

0.536657

Average Volume (3m)

3,653,177

Shares Outstanding

170,546,469

Dividend Yield

PE Ratio

-0.93

Earnings Per Share (EPS)

-0.59

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.57. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.2612 to US$ 1.60.

X4 Pharmaceuticals currently has 170,546,469 shares outstanding. The market capitalization of X4 Pharmaceuticals is US$97.23 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.93.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2003	-26.7066666667	0.75	0.77	0.5002	1885247	0.67170235	CS
4	-0.1403	-20.3333333333	0.69	0.8943	0.5002	2452501	0.70937468	CS
12	0.0297	5.71153846154	0.52	0.8943	0.2612	3653177	0.51784517	CS
26	-0.1353	-19.7518248175	0.685	0.8986	0.2612	2255725	0.5610789	CS
52	-0.279	-33.667189574	0.8287	1.6	0.2612	2468771	0.81424605	CS
156	-1.6003	-74.4325581395	2.15	2.575	0.2612	1815670	1.11381753	CS
260	-10.3503	-94.9568807339	10.9	11.11	0.2612	1161282	1.40594633	CS

XFOR - Frequently Asked Questions (FAQ)

What is the current X4 Pharmaceuticals share price?

The current share price of X4 Pharmaceuticals is US$ 0.5497

How many X4 Pharmaceuticals shares are in issue?

X4 Pharmaceuticals has 170,546,469 shares in issue

What is the market cap of X4 Pharmaceuticals?

The market capitalisation of X4 Pharmaceuticals is USD 97.23M

What is the 1 year trading range for X4 Pharmaceuticals share price?

X4 Pharmaceuticals has traded in the range of US$ 0.2612 to US$ 1.60 during the past year

What is the PE ratio of X4 Pharmaceuticals?

The price to earnings ratio of X4 Pharmaceuticals is -0.93

What is the reporting currency for X4 Pharmaceuticals?

X4 Pharmaceuticals reports financial results in USD

What is the latest annual profit for X4 Pharmaceuticals?

The latest annual profit of X4 Pharmaceuticals is USD -101.17M

What is the registered address of X4 Pharmaceuticals?

The registered address for X4 Pharmaceuticals is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, WILMINGTON, DELAWARE, 19810

What is the X4 Pharmaceuticals website address?

The website address for X4 Pharmaceuticals is www.x4pharma.com

Which industry sector does X4 Pharmaceuticals operate in?

X4 Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PHIOPhio Pharmaceuticals Corporation	US$ 7.221 (327.28%)	271.27M
SLRXSalarius Pharmaceuticals Inc	US$ 4.35 (177.96%)	115.79M
ATPCAgape ATP Corporation	US$ 2.1199 (68.25%)	82.69M
VRMEVerifyMe Inc	US$ 3.8202 (49.81%)	54.15M
XXII22nd Century Group Inc	US$ 6.875 (40.59%)	22.72M
EHGOEshallgo Inc	US$ 1.23 (-62.39%)	5.92M
CMTLComtech Telecommunications Corporation	US$ 2.32 (-43.83%)	3.96M
SVMHSRIVARU Holding Ltd	US$ 0.036 (-41.75%)	165.67M
LAESSEALSQ Corporation	US$ 3.439 (-39.98%)	70.83M
NAYANAYA Biosciences Inc	US$ 0.50 (-38.53%)	952.39k
GCTKGlucoTrack Inc	US$ 0.1414 (20.85%)	648.84M
PHIOPhio Pharmaceuticals Corporation	US$ 7.221 (327.28%)	271.27M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.063 (-28.49%)	185.68M
SVMHSRIVARU Holding Ltd	US$ 0.036 (-41.75%)	165.67M
NVDANVIDIA Corporation	US$ 132.24 (-2.70%)	165.66M